MJMG Holdings Inc. operating as Customs Biologics
$1,000,000.00
National Defence | Défense nationale
Innovation for Defence Excellence and and Security
FY 2020-2021
Canada
Develop and qualify a rapid Point-of-Care diagnostic test for the SARS-CoV-2 virus that causes Covid-19. The test will be run on a portable reader that will be capable of operating in a clinic or in t...